Adial Pharmaceuticals- Warrants (31/07/2023) Other Current Liabilities

As of the most recent data (June 2026), ADILW shows a other current liabilities of $2.5M. That compares with $540K in the prior-year period — up 362.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADILW's other current liabilities is now $2.5M (was $540K) — a 362.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Adial Pharmaceuticals- Warrants (31/07/2023) is outperforming or lagging.

Tracking ADILW's other current liabilities over time shows whether Adial Pharmaceuticals- Warrants (31/07/2023) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5M That compares with $540K in the prior-year period — up 362.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Adial Pharmaceuticals- Warrants (31/07/2023)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $2.5M) with ownership activity and broader fundamentals.

Adial Pharmaceuticals- Warrants (31/07/2023)'s other current liabilities is $2.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.